AAAAAA
Results:
1-11
|
Results: 11
Authors:
STROOMER JGW
ROOS JC
QUAK JJ
SPROLL M
HEIDER KH
KWAKKELSTEIN MO
SNOW GB
VANDONGEN GAMS
Citation: Jgw. Stroomer et al., TUMOR-TARGETING WITH THE ANTI-CD44V6 MONOCLONAL-ANTIBODY BIWA-1 IN HEAD AND NECK-CANCER PATIENTS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 21-21
Authors:
VANBOKHORSTDEVANDERSCHUEREN MAE
VANLEEUWEN PAM
SAUERWEIN HP
KUIK DJ
SNOW GB
QUAK JJ
Citation: Mae. Vanbokhorstdevanderschueren et al., ASSESSMENT OF MALNUTRITION PARAMETERS IN HEAD AND NECK-CANCER AND THEIR RELATION TO POSTOPERATIVE COMPLICATIONS, Head & neck, 19(5), 1997, pp. 419-425
Authors:
DEBREE R
ROOS JC
PLAIZIER MABD
QUAK JJ
VANKAMP GJ
DENHOLLANDER W
SNOW GB
VANDONGEN GAMS
Citation: R. Debree et al., SELECTION OF MONOCLONAL-ANTIBODY E48 IGG OR U36 IGG FOR ADJUVANT RADIOIMMUNOTHERAPY IN HEAD AND NECK-CANCER PATIENTS, British Journal of Cancer, 75(7), 1997, pp. 1049-1060
Authors:
VANDONGEN GAMS
BRAKENHOFF RM
TENBRINK C
VANGOG FB
DEBREE R
QUAK JJ
SNOW GB
Citation: Gams. Vandongen et al., SQUAMOUS-CELL CARCINOMA-ASSOCIATED ANTIGENS USED IN NOVEL STRATEGIES FOR THE DETECTION AND TREATMENT OF MINIMAL RESIDUAL HEAD AND NECK-CANCER, Anticancer research, 16(4C), 1996, pp. 2409-2413
Authors:
DEBREE R
ROOS JC
QUAK JJ
DENHOLLANDER W
SNOW GB
VANDONGEN GAMS
Citation: R. Debree et al., RADIOIMMUNOSCINTIGRAPHY AND BIODISTRIBUTION OF TC-99M-LABELED MONOCLONAL-ANTIBODY U36 IN PATIENTS WITH HEAD AND NECK-CANCER, Clinical cancer research, 1(6), 1995, pp. 591-598
Authors:
DEBREE R
ROOS JC
QUAK JJ
DENHOLLANDER W
WILHELM AJ
VANLINGEN A
SNOW GB
VANDONGEN GAMS
Citation: R. Debree et al., BIODISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY E48 IGG AND F(AB'(2)) IN PATIENTS WITH HEAD AND NECK-CANCER, Clinical cancer research, 1(3), 1995, pp. 277-286
Authors:
VANDONGEN GAMS
BRAKENHOFF RH
DEBREE R
GERRETSEN M
QUAK JJ
SNOW GB
Citation: Gams. Vandongen et al., PROGRESS IN RADIOIMMUNOTHERAPY OF HEAD AND NECK-CANCER (REVIEW), Oncology Reports, 1(1), 1994, pp. 259-264
Authors:
GERRETSEN M
QUAK JJ
BRAKENHOFF RH
SNOW GB
VANDONGEN GAMS
Citation: M. Gerretsen et al., THE FEASIBILITY OF RADIOIMMUNOTHERAPY OF HEAD AND NECK-CANCER, European journal of cancer. Part B, Oral oncology, 30B(2), 1994, pp. 82-87
Authors:
DEBREE R
ROOS JC
QUAK JJ
DENHOLLANDER W
VANDENBREKEL MWM
VANDERWAL JE
TOBI H
SNOW GB
VANDONGEN GAMS
Citation: R. Debree et al., CLINICAL IMAGING OF HEAD AND NECK-CANCER WITH TC-99M-LABELED MONOCLONAL-ANTIBODY E48 IGG OR F(AB')(2), The Journal of nuclear medicine, 35(5), 1994, pp. 775-783
Authors:
DEBREE R
ROOS JC
QUAK JJ
DENHOLLANDER W
SNOW GB
VANDONGEN GAMS
Citation: R. Debree et al., CLINICAL SCREENING OF MONOCLONAL-ANTIBODIES 323 A3, CSF-25 AND K928 FOR SUITABILITY OF TARGETING TUMORS IN THE UPPER AERODIGESTIVE AND RESPIRATORY-TRACT/, Nuclear medicine communications, 15(8), 1994, pp. 613-627
Authors:
SCHRIJVERS AHGJ
QUAK JJ
UYTERLINDE AM
VANWALSUM M
MEIJER CJLM
SNOW GB
VANDONGEN GAMS
Citation: Ahgj. Schrijvers et al., MAB U36, A NOVEL MONOCLONAL-ANTIBODY SUCCESSFUL IN IMMUNOTARGETING OFSQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Cancer research, 53(18), 1993, pp. 4383-4390
Risultati:
1-11
|